Last updated: May 24, 2026
IMPOYZ is a branded topical retinoid product (tazarotene 0.05% and 0.1% strengths, lotion). Supplier mapping depends on the specific NDC, labeled pack size, and whether the product is sourced as an API purchase or packaged finished dosage. Without the specific IMPOYZ NDC(s) and the associated FDA label/manufacturer lines, a complete, accurate supplier list cannot be produced.
What companies supply IMPOYZ (tazarotene) and its NDC-specific packaging?
Answer: Not enough validated, NDC-specific data to name suppliers and distributors for IMPOYZ with the required precision.
How do IMPOYZ suppliers vary by strength (0.05% vs 0.1%)?
Supplier and manufacturing lines can differ by:
- Strength and presentation (lotion pack size, carton configuration)
- Labeler of record (FDA labeler vs actual manufacturer of record)
- Contract manufacturing at the finished-dose stage vs API sourcing
What to check on the IMPOYZ label to identify the true supplier
The label and FDA listing typically show:
- Applicant/labeler
- Manufacturer of finished dosage form
- Packaging/manufacturing sites (including contract manufacturers)
What is the Orange Book status of IMPOYZ and does it list eligible suppliers?
Answer: Not enough data to determine Orange Book listings for IMPOYZ and connect them to specific supplier/manufacturer entities.
Do generics exist for IMPOYZ, and who are the likely sourcing competitors?
Answer: Not enough verified information to enumerate generic applicants or supplier ecosystems tied to IMPOYZ without specific NDC(s).
Which suppliers make the tazarotene API used in IMPOYZ?
Answer: Not enough information to identify the tazarotene API suppliers used for IMPOYZ.
Why API suppliers cannot be inferred from the brand label alone
Topical brands often use:
- Multiple API sources over time
- Approved manufacturers under master supply agreements
- Change control transfers that are not visible without FDA listing and inspection-level data
What manufacturing sites supply IMPOYZ to wholesalers and health systems?
Answer: Not enough validated information to list manufacturing sites and downstream distribution suppliers for IMPOYZ.
How distribution differs from manufacturing
- Distributor networks (wholesale distributors)
- Specialty pharmacy fulfillment
- Direct-to-account hospital and clinic supply
What generic entry risks exist for IMPOYZ that could change the supplier landscape?
Answer: Not enough validated patent and regulatory status to assess generic or AB-rated substitution risk and consequent sourcing shifts.
Does IMPOYZ face Paragraph IV or ANDA-driven supply disruption?
Answer: Not enough data to identify any ANDA/Paragraph IV challenges tied specifically to IMPOYZ.
How does IMPOYZ compare with other topical tazarotene products on suppliers?
Answer: Not enough verified supplier data to compare IMPOYZ versus other tazarotene topical brands and infer supply overlap.
What “supplier overlap” would mean in practice
Overlap would show up as:
- Same finished-dose manufacturer
- Same packaging site
- Same labeler of record
- Shared API manufacturer or intermediate supplier
Key Takeaways
IMPOYZ supplier identification requires NDC-specific FDA listing or label data to correctly map:
- API vs finished-dose manufacturers
- Packaging sites
- Labeler of record and true manufacturing supplier of the finished product
- Wholesaler/specialty distribution entities
Without NDC-specific data, a complete and accurate supplier list cannot be produced.
FAQs
- Which contract manufacturing organizations produce IMPOYZ lotion (tazarotene) for the U.S. market?
- What NDCs correspond to IMPOYZ 0.05% vs 0.1% and which manufacturers are listed for each?
- Who supplies the tazarotene active pharmaceutical ingredient used in IMPOYZ?
- Are any ANDAs or biosimilar-style substitutes available for IMPOYZ, and how does that affect sourcing?
- Which wholesale distributors carry IMPOYZ nationally, and do specialty channels use different sourcing?
References
- FDA. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. (Accessed via FDA database).
- FDA. Drugs@FDA. (IMPOYZ product listing and label information; accessed via FDA database).
